Back to Screener

Healthcare

Yulong Eco-Materials Limited(YECO)

Live Price

Offline

$0.0002

+0.00% today

1Y Change

-99.78%

Window

Jun 20, 2025 โ†’ Jun 16, 2026

Market Cap
โ€”
Revenue Growth
+264.7%
EPS Growth
+75.7%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 20, 2025 โ†’ Jun 16, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Yulong Eco-Materials Limited (YECO) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 99.8% across the available one-year price window (Jun 20, 2025 โ†’ Jun 16, 2026). Baseline metrics include revenue growth of +264.7%, EPS growth of +75.7%, a dividend yield of 0.0%. What stands out right now is revenue +264.7%, EPS +75.7%, free cash flow +96.2% with operating margin -38.8% and ROIC 6.1%. Valuation sits in the middle of the pack at price/sales 4.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines YECO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+264.7% vs +7.6% peer median

Operating Margin

Below sector median

-38.8% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2025 was reported on Jun 30, 2025, but the surprise data is still limited.

The operating story is still moving forward

Revenue is running at +264.7% and EPS at +75.7%, with operating margin around -38.8%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -5.9% over the next 5 trading days and finished higher after 1 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2025
Jun 30, 2025
โ€”+0.0%+2.2%-9.0%
2024
Dec 31, 2024
โ€”+0.0%-10.0%-10.0%
2024
Sep 30, 2024
โ€”+0.0%-10.0%-10.0%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

YECO

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

YECO Max Drawdown

-99.80%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for YECO and SPY.

Calendar-year return history is still loading or unavailable.
Yulong Eco-Materials Limited logo

Company Overview

Yulong Eco-Materials Limited

Other OTC

Cheyenne, WY, US
Visit yulongecomaterials.comCall IR206-734-4738

Yulong Eco-Materials Limited, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

Leadership
Daniel S. McKinney
IPO Date
Jun 29, 2015
Employees
284
Street Address
1621 Central Avenue
Mailing
Cheyenne, WY, 82001
Region
Cheyenne, WY, US
Reporting Currency
USD
Investor Line
206-734-4738
Last Updated
May 6, 2026
CIK: 0001607741ISIN: US9884971030CUSIP: 988497103
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
4.1
Price/Book
โ€”

Growth

Revenue
+264.7%
EPS
+75.7%
Free Cash Flow
+96.2%

Profitability

Gross Margin
0.0%
Operating Margin
-38.8%
Net Margin
-38.8%
ROE
1.7%
ROIC
6.1%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.42

Earnings Reports

๐Ÿ“… Last reportedJun 30, 2025
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Jun 30, 25
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 24
0.00
Est โ€”
โ€”
40.3B
Est โ€”
โ€”
โ€”
Sep 30, 24
0.01
Est โ€”
โ€”
138.0B
Est โ€”
โ€”
โ€”
Jun 30, 24
-0.02
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 24
-0.02
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 23
-0.02
Est โ€”
โ€”
48.9B
Est โ€”
โ€”
โ€”
Sep 30, 23
-0.05
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 23
-0.03
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 23
-0.03
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 22
-1.54
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 22
-1.28
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 22
-0.04
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 21
-0.05
Est โ€”
โ€”
118.9B
Est โ€”
โ€”
โ€”
Jun 30, 21
-0.01
Est โ€”
โ€”
118.9B
Est โ€”
โ€”
โ€”
Mar 31, 21
-0.02
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 17
-0.93
Est โ€”
โ€”
38722.6B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks